Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alun Parson"'
Autor:
Disha Malani, Olli Kallioniemi, Alun Parson, Satu Mustjoki, Minna Suvela, Caroline A. Heckman, Katja Suomi, Karoliina Laamanen, Laura Turunen, Kimmo Porkka, Ashwni Kumar, Bjørn Tore Gjertsen, Imre Vastrik, Muntasir Mamun Majumder, Pekka Ellonen, Evgeny Kulesskiy, Maija Wolf, Maria Nurmi, Oscar Brück, Astrid Muruimägi, Swapnil Potdar, Sari Kytölä, Krister Wennerberg, Samuli Eldfors, Tero Aittokallio, Simon Anders, Riikka Karjalainen, Bhagwan Yadav, Jani Saarela, Siv Knappila, Matti Kankainen, Aino Palva, Elina Lehtinen, Mika Kontro, Pirkko Mattila
Publikováno v:
Cancer Research. 79:458-458
Acute myeloid leukemia (AML) is an aggressive disease of clonal hematopoietic progenitor cells. Here, we applied ex-vivo drug sensitivity and resistance testing on AML patient cells with 362 emerging and 153 approved cancer drugs together with genomi
Autor:
Siv Knappila, Matti Kankainen, Aino Palva, Piia Mikkonen, Maria Nurmi, Imre Vastrik, Mika Kontro, Karjalainen Riikka, Sanna Timonen, Satu Mustjoki, Krister Wennerberg, Disha Malani, Maija Wolf, Oscar Brück, Pekka Ellonen, Ashwini Kumar, Tero Aittokallio, Pirkko Mattila, Laura Turunen, Caroline A. Heckman, Bhagwan Yadav, Karoliina Laamanen, Kimmo Porkka, Sari Kytölä, Swapnil Potdar, Alun Parson, Poojitha Ojamies, Astrid Murumägi, Evgeny Kulesskiy, Bjorn Tore Gjersten, Olli Kallioniemi, Muntasir Mamun Majumder, Minna Suvela, Jani Saarela, Samuli Eldfors, Simon Anders, Elina Lehtinen
Publikováno v:
Cancer Research. 78:3899-3899
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by multiple molecular subtypes and lack of effective targeted therapies. Here, we performed extensive molecular profiling and ex vivo drug testing with 515 approved and emerging ca
Autor:
Ianevski, Aleksandr1 (AUTHOR) aleksandr.ianevski@ntnu.no, Kulesskiy, Evgeny2 (AUTHOR) Evgeny.Kulesskiy@helsinki.fi, Krpina, Klara1 (AUTHOR) klarak@stud.ntnu.no, Lou, Guofeng3 (AUTHOR) guofeng.lou@medisin.uio.no, Aman, Yahyah3 (AUTHOR) yahyah.aman@medisin.uio.no, Bugai, Andrii4 (AUTHOR) andrii.bugai@helsinki.fi, Aasumets, Koit5 (AUTHOR) koitaasumets@gmail.com, Akimov, Yevhen2 (AUTHOR) yevhen.akimov@helsinki.fi, Bulanova, Daria2 (AUTHOR) daria.bulanova@helsinki.fi, Gildemann, Kiira5 (AUTHOR) kiira.gildemann@ut.ee, Arutyunyan, Albert F.6 (AUTHOR) abosiy@yandex.ru, Susova, Olga Yu.7 (AUTHOR) susovaolga@gmail.com, Zhuze, Alexei L.6 (AUTHOR) zhuze@eimb.ru, Ji, Ping1 (AUTHOR) ping.ji@ntnu.no, Wang, Wei1 (AUTHOR) wei.wang@ntnu.no, Holien, Toril1,8 (AUTHOR) toril.holien@ntnu.no, Bugge, Marit1 (AUTHOR) marit.bugge@ntnu.no, Zusinaite, Eva5 (AUTHOR) Eva.Zusinaite@ut.ee, Oksenych, Valentyn1 (AUTHOR) valentyn.oksenych@ntnu.no, Lysvand, Hilde1 (AUTHOR) Hilde.Lysvand@ntnu.no
Publikováno v:
Cancers. Jun2020, Vol. 12 Issue 6, p1694. 1p.